Please login to the form below
MOVe-AHEAD trial
This page shows the latest MOVe-AHEAD trial news and features for those working in and with pharma, biotech and healthcare.
Merck and Ridgeback’s COVID-19 pill fails to prevent infection within households
The phase 3 MOVe-AHEAD trial evaluated the safety and efficacy of Lagevrio compared to placebo in preventing the spread of SARS-CoV-2 within households. ... Li added that, because MOVe-AHEAD was not a treatment trial, these latest results will not impact
Latest news
-
Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
The MOVe-AHEAD trial will test whether the drug prevents infection in those living in the same household as someone with confirmed COVID-19. ... The second stage of the MOVe-OUT trial – a global phase 3, placebo-controlled, double-blind, multi-site
-
Bayer, Merck’s high-risk heart failure drug comes good in phase 3
In 2016 they opted to move ahead with the phase 3 trial despite mixed results in the phase 2 SOCRATES-REDUCED trial. ... added. At the moment there are no studies involving SGLT2 inhibitors that have competed in worsening heart failure, he suggested
-
Neoantigen player Achilles gets OK for first clinical trial
The Stevenage, UK biotech is developing personalised T cell therapies targeted at clonal ‘neoantigens’ – antigens that are found in cancerous but not healthy tissues – and will now move ahead with a ... hopes to start a second trial in advanced
-
Biogen hands out $120m upfront for Remedy stroke drug
Undeterred, Remedy sought a meeting with the FDA that not only gave the go-ahead for the start of the firm's phase III CHARM trial, but has also granted orphan ... category. And with its own portfolio of central nervous system drugs, Biogen has the
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn
- Landscape review reveals £1.1bn of UK funding for rare diseases
- Cancer Research UK partners with French cancer institute
- New diagnosis pathway has been launched to mark European Myeloma Day
- Impacting Lives with Rare Disease Education
- Sandoz biosimilar receives EC approval to treat MS
No results were found
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
